Ozempic pill vs injection: what actually differs
For planning and record-keeping only — not medical advice. Your dose and schedule are set by your prescriber.
Yes, there is an Ozempic pill. Since May 2026 US pharmacies carry Ozempic tablets — semaglutide taken once daily at 1.5 mg, 4 mg, or 9 mg — alongside the weekly injection pen at 0.25 mg to 2 mg. Both are approved for type 2 diabetes. Which one you were prescribed is your prescriber's decision.
Two forms, one brand name
Ozempic is now two products. The injection is the multi-dose pen that has been on the US market since 2017, given once a week. The tablets are the oral form the FDA approved on February 4, 2026, which reached US pharmacies on May 4, 2026, and are taken every day. Same brand, same molecule, different dosage form, different schedule, different milligram numbers.
| Form | Frequency | Doses | Approved US indication | Source |
|---|---|---|---|---|
| Ozempic injection — multi-dose pen | Once weekly | 0.25, 0.5, 1, 2 mg | Type 2 diabetes in adults | Prescribing information (checked 2026-08-18) |
| Ozempic tablets — oral | Once daily | 1.5, 4, 9 mg (start 1.5 mg) | Type 2 diabetes in adults, plus reduced risk of major cardiovascular events in high-risk adults with type 2 diabetes | Novo Nordisk announcement (checked 2026-08-18) |
The milligram numbers are not translations of each other. A weekly injection dose and a daily tablet strength are measured on different schedules, and nothing on this page converts between them. Every approved weekly step, with the pen presentation behind it, sits in the semaglutide dosage chart; the strength written for you comes from your prescriber.
The approved use is worth reading exactly as written. Ozempic tablets are approved for adults with type 2 diabetes, as an addition to diet and exercise, to improve blood sugar control, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes at high risk. Chronic weight management is not on that label; the other semaglutide brand carries that indication, and it now has a tablet of its own — Wegovy pill vs injection covers those strengths. What a label covers and what a particular prescription is for are separate questions, and the second one belongs to the prescriber who wrote it.
What happened to Rybelsus
Oral semaglutide is not new. It was sold in the US as Rybelsus at 3 mg, 7 mg, and 14 mg. In 2026 Novo Nordisk retired that brand: shipments stopped around May 2026 and remaining pharmacy stock ran out by roughly July 2026, with oral semaglutide continuing under the Ozempic name instead.
The new strengths come from a bioequivalence study rather than a new molecule, which is why the labeled milligram numbers are lower at comparable exposure. That is a fact about the product, not an instruction. If you hold or recently filled a Rybelsus prescription, the strength that now corresponds to it is a question for your prescriber or pharmacist, and only they can answer it.
What this means for tracking
This site is built around weekly injections. Every tool here — dates, pens, injection sites — assumes a shot on a fixed weekday, so a daily tablet falls outside what any of them were designed for. That is worth stating plainly rather than stretching the tools to fit.
Weekly injection: what we cover
- Titration dates counted from your first injection date
- Injection-site rotation across abdomen, thigh, and upper arm
- The pen’s 56-day in-use window, one timer per pen
Daily tablet: what changes
- A dose every day instead of one day a week
- No pen, so no doses-left count and no 56-day window
- The weekly planners and timers on this site do not apply
- Ask your pharmacist how the tablet’s daily schedule is meant to work
On the weekly injection, three pages cover the counts: the titration date planner turns a first-injection date into the earliest label date for each step, tracking the weekly injection walks through the pen-specific log, and the semaglutide tracker page covers what the injectable forms share at molecule level. On the daily tablet, none of that applies, and the schedule itself is your pharmacist's and prescriber's territory.
KeepAlong — GLP-1 shot tracker & planning tools
If you're on the weekly injection, KeepAlong handles the parts a daily pill doesn't have: shot-day reminders, injection-site rotation, and the pen's 56-day in-use window.
The app is launching soon. The web tools on this site are free — no sign-up needed.
The KeepAlong GLP-1 shot tracker app is built for those weekly counts, and this page claims nothing beyond that: a once-daily tablet needs a plain daily reminder, which any phone already has.
Frequently asked questions
Is there an Ozempic pill?
Yes. The FDA approved Ozempic tablets on February 4, 2026, and they reached US pharmacies on May 4, 2026. They contain semaglutide, the same molecule as the injection, and are taken once daily rather than once a week. The injectable pen continues to be sold as a separate product.
What are the Ozempic tablet doses?
Ozempic tablets come in three strengths — 1.5 mg, 4 mg, and 9 mg — taken once daily, with treatment starting at 1.5 mg. Those numbers are separate from the injection’s weekly 0.25, 0.5, 1, and 2 mg, and the two sets are not conversions of each other. Your prescriber writes the strength.
Is Rybelsus discontinued?
In the US, yes. Novo Nordisk wound down the Rybelsus brand during 2026: shipments stopped around May 2026 and remaining pharmacy stock ran out by roughly July 2026. Oral semaglutide now carries the Ozempic name at different strengths. Which strength replaces a Rybelsus prescription is a question for your prescriber or pharmacist.
Can you track Ozempic tablets with a shot tracker?
Not usefully. A shot tracker is built around a weekly rhythm: one injection date, doses left in a multi-dose pen, and that pen’s 56-day in-use window. A daily tablet has none of those counts. What a once-daily medication needs is an ordinary daily reminder, not injection scheduling.
KeepAlong is an independent app and website. Not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly.